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Introduction {#sec1}
============

Coronaviruses (CoVs), long considered of high veterinary impact exclusively, are now generally recognized as zoonotic threats of pandemic potential in consequence of the 2002/2003 outbreak of severe acute respiratory syndrome (SARS) and the emergence of Middle East respiratory syndrome (MERS) in 2012 ([@bib6]). SARS-CoV was contained within 3 months after its discovery, while MERS-CoV causes a classical zoonotic infection with limited human-to-human spread and, as yet, is incapable of sustained community transmission ([@bib26], [@bib43]). However, four other respiratory coronaviruses---alphacoronaviruses NL63 and 229E and lineage A betacoronaviruses OC43 and HKU1---successfully breached the species barrier and are currently maintained in the human population worldwide through continuous circulation ([@bib28], [@bib5]). Conceivably, the study of these genuine human coronaviruses (HCoVs) may yield clues to what is required for viral adaptation to the human host and thereby increase our understanding of the probabilities and risks of coronavirus cross-species transmission.

OC43 and HKU1, while generally associated with benign common colds in healthy immunocompetent individuals, may cause significant morbidity and even mortality in the frail ([@bib23], [@bib38]). OC43, the best-studied HCoV, apparently arose relatively recently, 120 to 70 years ago, with the most recent common ancestor of all extant OC43 variants dating to the 1950s ([@bib17], [@bib34], [@bib35]). OC43 groups in the species *Betacoronavirus-1* (β1CoV), together with highly related viruses from ruminants (bovine coronavirus, BCoV), swine (porcine hemagglutinating encephalomyelitis virus, PHEV), equines (equine coronavirus, ECoV), leporids (rabbit coronavirus HKU14, RbCoV), and canines (canine respiratory coronavirus, CRCoV) ([@bib5]; [Figure 1](#fig1){ref-type="fig"} A). The extraordinary radiation of β1CoVs might be explained from their receptor usage, as they attach to 9-*O*-acetylated sialic acids (9-*O*-Ac-Sias) ([@bib21]), i.e., glycan components common in mammals and birds ([@bib30]). Paradoxically, however, most β1CoVs, including OC43, have very narrow host ranges. They form distinct monophyletic clades congruent with host selectivity, and phylogenetic evidence strongly argues against recurrent inter-species transmissions ([@bib17], [@bib35]; see also [Figure 1](#fig1){ref-type="fig"}A). With the emergence of OC43 seemingly sparked by a singular one-time zoonotic event, the founder virus likely possessed unique traits already to allow efficient infection of, and transmission among, humans. In turn, these traits and subsequent adaptations to the new niche must have closed the door on reintroduction of the virus into animals. Despite the close genetic relationship between OC43 and BCoV-Mebus, particularly (96.6% identity across their entire genomes), their high-prevalence endemicity/enzooticity, and the scale and frequency of interactions between their host species, there is no evidence of OC43 spreading to cattle nor of BCoV (or any other β1CoV) efficiently spreading into humans ([Figure 1](#fig1){ref-type="fig"}A).Figure 1Loss of HE-Mediated Receptor Binding in Human Betacoronaviruses(A) Evolutionary relationships among lineage A betacoronaviruses. Neighbor-joining tree based on βCoV lineage A ORF1b sequences in the NCBI database (n = 206), with 100% bootstrap support for all major branches. Evolutionary distances were computed using the Maximum Composite Likelihood method in MEGA6 ([@bib29]). The positions of human coronaviruses OC43 and HKU1 are highlighted relative to those of animal lineage A betacoronaviruses, including the various β1CoV subspecies and classical mouse hepatitis virus-type murine coronavirus (MuCoV). ChRCoV-HKU24, Chinese rat coronavirus HKU24 ([@bib18]); LAMV, Longquan Aa mouse coronavirus ([@bib37]); LRLV, Longquan RI rat coronavirus ([@bib37]). The position of CRCoV, a recent split-off of BCoV, is indicated by a red dot. (See also [Figure S1](#mmc1){ref-type="supplementary-material"}.)(B) HE^0^-Fc lectins (2-fold serial dilutions, starting at 50 ng/μL) were compared by sp-LBA for relative binding to BSM (with 50 ng/μL BCoV-HE^0^-Fc set at 100%).(C) Conventional HAA with 2-fold serial dilutions of HE^0^-Fc fusion proteins of β1CoV members and HCoV-HKU1 (starting at 25 ng/well). Wells positive for hemagglutination are encircled.(D) High-sensitivity nanobead HAA. Non-complexed nanobeads ("beads only") and nanobeads complexed with lectin-inactive mutant BCoV HE^0^ F^211^A were included as negative controls.

β1CoV attachment involves two distinct types of surface projections: large 20-nm "spikes" comprised of homotrimers of the class I fusion protein S and stubby 8-nm protrusions that are homodimeric assemblies of the hemagglutinin-esterase protein HE ([@bib5]). The S protein, common to all coronaviruses, mediates receptor binding and fusion of the viral and host membranes ([@bib10]). HEs are found in toroviruses and in influenza C and D viruses, but among coronaviruses, only in lineage A betacoronaviruses ([@bib4], [@bib5], [@bib9], [@bib21]). HE monomers have a bimodular structure with a carbohydrate-binding ("lectin") domain appended to an enzymatically active sialate-*O*-acetylesterase ("esterase") domain ([@bib13], [@bib27], [@bib42]). Typically, in β1CoVs, both the spikes and HEs bind 9-*O*-Ac-Sias, while the HE esterase domain promotes virus elution through receptor destruction. In consequence of the opposing activities of receptor binding and receptor destruction, β1CoV attachment to sialoglycans is dynamic and reversible. Thus, dead-end binding of virions to decoy receptors in oropharyngeal, respiratory, and gastrointestinal mucus may be prevented. Moreover, in infected host cells, HE-mediated receptor destruction is essential for efficient release of viral progeny ([@bib7]).

Here we present a comprehensive structure-function study of OC43 HE. We demonstrate that over decades after OC43's introduction, its evolution was marked by a progressive loss of HE receptor-binding activity through the accumulation of select mutations in the HE lectin domain. The effect of these mutations on the organization of the carbohydrate-binding site (CBS) and on receptor binding is explained from the crystal structure of the BCoV HE-receptor complex ([@bib42]) and visualized directly by the structure of a contemporary OC43 HE solved to 2.45Å resolution. Evidence is provided that loss of HE receptor-binding activity resulted in a reduction of virion-associated esterase activity toward multivalent clustered substrates. We propose that inactivation of the HE lectin domain altered the balance between virion binding and esterase-mediated virion elution, apparently as an adaptation to the sialoglycome of the human respiratory tract, and we speculate that this may be a contributing factor to host selectivity. This view is supported by our observation that the HE of HCoV-HKU1 also lost its receptor-binding properties. A mechanism is proposed in which accessibility of receptors to destruction depends on HE lectin function in relation to S-HE size differences and in which the balance between attachment and catalysis-driven virion elution is a determinant of host tropism.

Results and Discussion {#sec2}
======================

Lectin Properties of β1CoV HEs {#sec2.1}
------------------------------

A comprehensive set of β1CoV HEs, expressed as esterase-inactive Fc-fusion proteins (HE^0^-Fc), was compared for their Sia-binding properties. In accordance with previous findings ([@bib16]), the HEs of most animal β1CoVs bound to bovine submaxillary mucin (BSM) in a 9-*O*-Ac-Sia-dependent fashion in solid-phase lectin-binding assays (sp-LBA; [Figure 1](#fig1){ref-type="fig"}B). Remarkably, however, those of PHEV strain VW572 and prototypic OC43 strain USA/1967 (also known as ATCC-VR759; [@bib22]) showed no detectable binding. In hemagglutination assays (HAA), more sensitive than sp-LBA, PHEV HE^0^ tested positive, albeit weakly ([Figure 1](#fig1){ref-type="fig"}C). OC43 USA/1967 HE^0^, however, did not hemagglutinate. To augment HAA sensitivity through multivalency-driven high-avidity binding, we complexed HE^0^-Fc chimeras to protein A-coated nanobeads ([Figure 1](#fig1){ref-type="fig"}D). For PHEV HE^0^, sensitivity was increased 250-fold as compared to the standard assay. Under these conditions, modest, but reproducible, hemagglutination by OC43 USA/1967 HE^0^ was detected ([Figure 1](#fig1){ref-type="fig"}D). Apparently, it has lost most, though not all, of its lectin function.

Our observations prompted the question of whether loss of HE lectin activity is a strain-specific trait resulting from adaptation to in vitro propagation or a characteristic also shared by naturally occurring OC43 viruses. We therefore RT-PCR-amplified HE genes from more recent sputum-derived OC43 strains (respiratory season 2005). The encoded proteins OC43/NL/A/2005 and OC43/NL/B/2005 HE^0^, representative for the two major HE lineages in OC43 (designated "A" and "B," [Figure S1](#mmc1){ref-type="supplementary-material"} and vide infra), did not show any detectable binding by sp-LBA or nanobead HAA ([Figures 1](#fig1){ref-type="fig"}B--1D). Apparently, loss of affinity for 9-*O*-Ac-Sias as seen for OC43/USA/1967 HE is not an artifact. In fact, the data suggest that HEs of contemporary OC43 variants have lost receptor-binding activity altogether.

Lectin Function of OC43 HE Impeded by a Combination of Mutations {#sec2.2}
----------------------------------------------------------------

The HE ectodomains of BCoV strain Mebus and OC43 USA/1967, each 365 residues in length, differ at 18 positions only ([Figures 2](#fig2){ref-type="fig"}A and 2B). To identify the differences accounting for loss of lectin activity in OC43 USA/1967 HE, we introduced OC43-specific substitutions in BCoV-Mebus HE^0^-Fc, in sets and individually, and tested for a reduction in lectin activity by HAA ([Figure S2](#mmc1){ref-type="supplementary-material"}A). In a complementary approach, OC43 HE residues were systematically replaced by BCoV HE orthologs ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2D). The results show that the mutations in the esterase and MP domains of OC43 USA/1967 HE ([Figures 2](#fig2){ref-type="fig"}A--2C; [Figure S2](#mmc1){ref-type="supplementary-material"}A) do not affect ligand binding. In fact, loss of 9-*O*-Ac-Sia binding can be attributed to four out of eight substitutions in the lectin domain (T^114^N, R^177^P, E^178^Q, and F^247^L; [Figures S2](#mmc1){ref-type="supplementary-material"}A--S2D). Combined replacement of these residues in OC43 USA/1967 HE^0^ by BCoV orthologs restored binding affinity to that of BCoV-Mebus HE ([Figure 2](#fig2){ref-type="fig"}C). Individual replacement of these residues in the context of a restored OC43 USA/1967 HE ("TREF") showed that each mutation affects receptor binding to more (T^114^N, E^178^Q) or lesser (R^177^P, F^247^L) extent ([Figure 2](#fig2){ref-type="fig"}C).Figure 2Loss of OC43 USA/1967 HE^0^ Lectin Affinity Attributed to a Combination of Four Mutations(A) Alignment of BCoV, OC43 USA/1967, OC43 NL/A/2005, and OC43 NL/B/2005 HE with sequences color coded by domain (membrane-proximal domain, red; esterase domain, green; lectin domain, blue). Residues crucial for esterase activity (SGNDH) are annotated. Amino acid differences are marked in black. N^114^ substituting for Thr is colored in cyan, and the resulting *N*-linked glycosylation site (NRS) marked with red dots. D^220^ is marked with a red asterisk.(B) Overall structure of BCoV HE (PDB: [3CL5](pdb:3CL5){#intref0025}) with mutations in OC43 USA/1967 HE indicated. Domain coloring as in (A).(C) Comparison of binding affinities of BCoV HE^0^, OC43 USA/1967 HE^0^, and derivatives by sp-LBA. BCoV, BCoV-Mebus HE^0^; OC43 TREF, OC43 USA/1967 HE^0^ with N^114^, P^177^, Q^178^ and L^247^ replaced by BCoV-Mebus HE orthologs; T^114^N, R^177^P, E^178^Q, and F^247^L, TREF derivatives with indicated residues re-converted to the autologous OC43 orthologs.(D) Conventional HAA with BCoV-Mebus HE^0^ T^114^N expressed in HEK293T or HEK293S GnTI^−^ cells. (See also [Figure S2](#mmc1){ref-type="supplementary-material"}.)

The impact of these mutations on 9-*O*-Ac-Sia binding can be understood from the crystal structure of the BCoV-Mebus HE-receptor complex ([@bib42]). The BCoV HE receptor-binding region is comprised of six surface loops, five grafted on the beta-sandwich core of the lectin domain and one emanating from the esterase domain ([Figure S3](#mmc1){ref-type="supplementary-material"}A). The actual carbohydrate-binding site consists of a deep hydrophobic pocket P1 and a more shallow hydrophobic depression P2 that accommodate the methyl groups of the Sia-9-*O*- and −5-*N*-acetyl moieties, respectively ([Figure 4](#fig4){ref-type="fig"}E). The side chain of F^211^ (a residue in the β12/β13 β-hairpin) separates P1 from P2 and, in the HE-receptor complex, intercalates between the Sia-acetyl groups. Ligand binding, thus largely based on shape complementarity and hydrophobic interactions, is stabilized by extensive protein-sugar hydrogen bonding, particularly involving the β7--β10 β-hairpin, through main chain atoms of L^212^ and N^214^ to the sialate-5-*N*-acyl amide and the Sia carboxylate, respectively, and through the side-chain hydroxyl of S^213^ to the sialate-C8-hydroxyl and -C9-acyl oxygen. Y^184^ in the β5-β6 loop (residues 176--185) is particularly important for ligand binding as its side-chain hydroxyl group hydrogen bonds with the sialate-9-*O*-acetyl carbonyl, while its aromatic ring together with the side chains of F^211^, L^266^, and L^267^ walls the P1 pocket that is key to receptor recognition ([Figure 4](#fig4){ref-type="fig"}E).

Residues of the α5-α6 loop (residues 111--118) do not directly contact the ligand. However, the T^114^N substitution in OC43 HE created a novel *N*-linked glycosylation site (TTS→NRS) ([Figure 2](#fig2){ref-type="fig"}A). A glycan attached to this site would extend into the CBS and potentially reduce receptor binding through steric hindrance. Indeed, the introduction of this glycosylation site in BCoV HE^0^ resulted in an almost complete loss of binding as detected by sp-LBA ([Figure 2](#fig2){ref-type="fig"}C) and a 250-fold loss of apparent binding affinity as measured by HAA ([Figure 2](#fig2){ref-type="fig"}D; [Figure S2](#mmc1){ref-type="supplementary-material"}A). The same mutant protein, but now expressed in *N*-acetyl glucosamine transferase I (GnTI)-deficient HEK293S GnTI^−^ cells instead of HEK293T cells, showed a less pronounced loss of binding affinity (30-fold in HAA; [Figure 2](#fig2){ref-type="fig"}D). The data show that glycosylation at N^114^ indeed reduces the affinity of the HE lectin domain for 9-*O*-Ac-Sias and that this reduction is positively correlated with glycan size/complexity.

In BCoV HE, E^178^ fixates the β5-β6 loop by engaging in double hydrogen bonds with the backbone nitrogen atoms of S^155^ and A^156^ in the β4-β5 loop ([Figure S3](#mmc1){ref-type="supplementary-material"}B). We offer that in OC43 HE, the replacement by Gln and consequential loss of inter-loop hydrogen bonding destabilizes the β5-β6 loop and that its increased flexibility impairs the Sia-binding site, presumably by affecting the critical P1 pocket. The consequences of the other two substitutions in OC43 USA/1967 HE are less evident, although it can be envisaged that the R^177^P replacement might again affect folding and/or stability of the β5-β6 loop and thereby indirectly the positioning of the critical Y^184^ residue. The F^247^L substitution is more difficult to explain as the affected residue locates to the core of the HE lectin domain, distal to the CBS, and the mutation apparently decreases ligand binding through indirect long-range effects. The combined data show for the early OC43 isolate USA/1967 that the reduced lectin activity of its HE resulted not from a single but from a combination of mutations.

Progressive Loss of HE Lectin Function during OC43 Evolution {#sec2.3}
------------------------------------------------------------

In the course of this study, many full genome sequences from OC43 field variants from the US, Western Europe, and China, well documented with respect to place and date of virus sampling, became available in GenBank. This wealth of information allowed us to study the recent evolution of the OC43 HE protein. In phylograms, in accordance with the presumptive date of OC43 emergence, the HE of the USA/1967 strain is placed close to the root ([Figure S1](#mmc1){ref-type="supplementary-material"}). In the decades thereafter, the HE proteins divided into three clades. Clade C, the least populous, is comprised of HEs from OC43 strains sampled in the early 1990s with no recent representatives and may have been replaced by clades A and B. Comparative sequence analysis in combination with structure-function analysis showed that both type A and B HEs acquired several mutations in the lectin domain additional to those already present in OC43 USA/1967, which explains the loss of HE receptor binding in extant OC43 variants. Unexpectedly, in B-type HEs, but not in those of types A and C, glycosylation at N^114^ was lost again due to a S^116^A substitution (NRS→NRA). Further inspection revealed the replacement in B-type OC43 HEs of D^220^ by Y. D^220^ is part of a potassium ion-coordinating metal-binding site (MBS), a signature element of coronavirus HE lectin domains involved in the organization of the Sia-binding site ([Figure 3](#fig3){ref-type="fig"} A) ([@bib42]). The MBS is formed by main-chain carbonyl atoms of S^221^, E^265^, and L^267^, together with the side chains of Q^222^, S^263^, and D^220^, the latter of which is particularly important as it balances the positive charge of the metal ion. In BCoV HE^0^, the D^220^Y mutation resulted in loss of all detectable binding to 9-*O*-Ac-Sia ([Figures 3](#fig3){ref-type="fig"}B and 3C). In turn, a Y^220^D back mutation in the type B HE of OC43 NL/B/2005 restored Sia-binding activity to levels detectable by high-sensitivity nanobead HAA ([Figure 3](#fig3){ref-type="fig"}D). Again, the structure of the BCoV HE-receptor complex provides an explanation for the detrimental effect of the mutation. As L^266^ and L^267^ are in a loop that is stabilized through the coordination of the potassium ion, disruption of the MBS might affect the folding of this loop, the positioning of the Leu residues, and thereby the structure of receptor-binding pocket P1.Figure 3Complete Loss of HE Lectin Function during OC43 Evolution due to Progressive Accumulation of Mutations(A) Close up of the BCoV-Mebus HE CBS in complex with α-Neu5,9Ac~2~2Me (in sticks). Residues comprising the metal-binding site (MBS) are also shown in sticks, the potassium ion is shown as a magenta sphere, and interactions between the metal ion and coordinating amino acid residues as red dashed lines.(B) Disruption of the MBS in BCoV HE leads to loss of lectin affinity. sp-LBA as in [Figure 1](#fig1){ref-type="fig"}B.(C) Disruption of the BCoV HE lectin MBS through D^220^Y substitution renders receptor binding non-detectable even by high-sensitivity nanobead HAA.(D) The Y^220^D mutation partially restores lectin affinity of OC43 NL/B/2005 HE^0^.(E) D^220^H substitution in BCoV HE results in thermolability of receptor binding. Conventional HAA before (4°C) and after (37°C) a temperature shift up.(F) Receptor binding of OC43 NL/A/2005 HE^0^ and derivatives as determined by sp-LBA. In OC43 NL/A/2005 HE^0^, N^114^, P^177^, Q^178^, and L^247^ were replaced by BCoV-Mebus HE orthologs (TREF), in combination with (1) H^220^D substitution (TREF, H^220^D), (2) repair of the β5-β6 loop by substituting D^183^YYY^186^ for IIT (TREF, −IIT), or (3) H^220^D and repair of the β5-β6 loop (TREF, H^220^D, −IIT).

Remarkably, also in A-type OC43 HEs, the MBS was targeted by substitution of D^220^, now by His ([Figure 2](#fig2){ref-type="fig"}A). As evident from comparative sequence and phylogenetic analysis, the substitutions in A- and B-type HEs were independent events, and their selection must be ascribed to convergent evolution. Again, D^220^H mutation in BCoV HE resulted in loss of detectable Sia binding as measured by sp-LBA ([Figure 3](#fig3){ref-type="fig"}B). Unexpectedly, however, in conventional HAA routinely performed at 4°C, wild-type and mutant BCoV HEs hemagglutinated to similar extent ([Figure 3](#fig3){ref-type="fig"}E). The effect of the mutation became evident after a shift up to 37°C, upon which hemagglutination with wild-type BCoV HE remained stable while that of the mutant protein resolved ([Figure 3](#fig3){ref-type="fig"}E). Apparently, substitution of D^220^ by His is less disruptive than by Tyr, but results in thermolability of HE receptor binding, likely to cause reduced binding affinity under physiological conditions. Repair of the OC43-specific substitutions already present in the HE of the 1967 strain ([Figure 2](#fig2){ref-type="fig"}A), in conjunction with a H^220^D back substitution, did not restore lectin activity of OC43 NL/A/2005 HE ([Figure 3](#fig3){ref-type="fig"}F), suggesting the presence of at least one additional mutation to prevent receptor binding. Comparative sequence analysis revealed a major change uniformly shared by A-type HEs again in the β5-β6 loop, with four adjacent residues 183--186, Asp-Tyr-Tyr-Tyr, replaced by Ile-Ile-Thr ([Figure 2](#fig2){ref-type="fig"}A), apparently as a result of a double frameshift mutation ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Repair of this mutation, in combination with restorative changes at the other five sites, was required for OC43 NL/A/2005 HE to regain receptor-binding activity ([Figure 3](#fig3){ref-type="fig"}F). The impact of the β5-β6 loop mutation is easily understood from the structure of the BCoV HE-receptor complex, as it involved loss of Y^184^, an essential residue for ligand binding.

Crystal Structure of an OC43A-type HE {#sec2.4}
-------------------------------------

To assess the consequences of the combined mutations in the type A HE lectin domain, we determined the crystal structure of OC43 NL/A/2005 HE at 2.45Å resolution (for crystallographic details, see [Table S1](#mmc1){ref-type="supplementary-material"}; PDB: [5N11](pdb:5N11){#intref0010}). In overall fold, OC43 HE is highly similar to other coronavirus HEs ([Figure 4](#fig4){ref-type="fig"} ). Differences in the esterase domain are limited to substitution of five surface residues, none likely to impair esterase function or activity. OC43 HE is also identical to BCoV HE in most of its lectin domain, particularly in the beta-sandwich core, but the loops shaping the receptor-binding site have changed dramatically ([Figure 4](#fig4){ref-type="fig"}D; [Figure S3](#mmc1){ref-type="supplementary-material"}D). The β11-β12 and β5-β6 loops are disordered, suggestive of extensive flexibility, in the case of the latter loop in accordance with loss of E^178^-mediated inter-loop hydrogen bonding. Those (parts of the) loops that can be visualized are reoriented and displaced with respect to their original position in BCoV HE, utterly destroying the CBS. For example the β7/β10 β-hairpin, comprising F^211^, L^212^, S^213^, and N^214^ that are key to protein-ligand interaction in BCoV HE ([@bib42]), has shifted by approximately 7Å ([Figure 4](#fig4){ref-type="fig"}D). The P1 pocket, arguably the most critical element of the CBS, no longer exists as (1) F^211^ is no longer at its original position and its side chain is rotated by 90°, (2) Y^184^ was lost as a result of the frameshift mutation in the β5-β6 loop, and (3) the side chains of L^266^ and L^267^ are reoriented apparently due to the loss of the MBS ([Figures 4](#fig4){ref-type="fig"}E and 4F). Finally, attached to N^114^ is an *N*-acetylglucosamine, providing formal evidence that the newly introduced glycosylation site in OC43 HEs is functional. Although the remaining residues of the sugar chain could not be visualized, the glycan would stretch across the remains of the CBS ([Figure 4](#fig4){ref-type="fig"}F).Figure 4Crystal Structure of OC43 NL/A/2005 HE(A and B) Side-by-side cartoon representations of the overall crystal structures of BCoV-Mebus HE (A) and OC43 NL/A/2005 HE (B). HE monomers are colored gray or by domain (as in [Figure 2](#fig2){ref-type="fig"}A).(C) BCoV and OC43 HE have identical esterase catalytic sites. Overlay of BCoV (blue) and OC43 NL/A/2005 (green) HE esterase domains. Cartoon representations with residues crucial for activity indicated as sticks.(D) Overlay of BCoV and OC43 NL/A/2005 HE lectin domains. F^211^ indicated with sticks.(E) 9-*O*-Ac-Sia (with carbon atoms in cyan) binding in the BCoV-Mebus HE lectin CBS as observed in the crystal complex (PDB: [3CL5](pdb:3CL5){#intref0030}). Close up with contacting amino acid side chains shown in stick representation. Hydrogen bonds are shown as black dashed lines, and hydrophobic interactions with the Sia-9-*O*- and −5-*N*-methyl groups as thin gray lines. P1 and P2 indicate the pocket and hydrophobic depression, which accommodate the methyl groups of the Sia-9-*O*- and −5-*N*-acetyls, respectively.(F) Close up of the inactivated CBS of OC43 NL/A/2005 HE. Residues corresponding to those in (E) are in stick representation and colored by atom type. NAG, *N*-acetylglucosamine attached to N^114^, is shown in stick representation. (See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.)

Loss of HE Receptor Binding in HCoV-HKU1: A Case of Convergent Evolution? {#sec2.5}
-------------------------------------------------------------------------

OC43 and HKU1 occupy the same niche, prompting the question whether they have been subject to similar selective constraints. HCoV-HKU1 is also a lineage A betacoronavirus but distantly enough related to the β1CoVs to be assigned to a separate species ([@bib5]) ([Figure 1](#fig1){ref-type="fig"}A). Like OC43, HCoV-HKU1 binds to 9-*O*-Ac-Sia receptor determinants via its spike ([@bib11]), and it possesses an HE ([@bib39]). The HE of the prototypical HCoV-HKU1 2005 Hong Kong genotype A strain ([@bib40]) tested negative for 9-*O*-Ac-Sia binding by sp-LBA, standard HAA, and nanobead HAA ([Figures 1](#fig1){ref-type="fig"}B--1D). Comparative sequence analysis, including genotypes A and B, of HCoV-HKU1 ([@bib40]) shows that the HKU1 HE has undergone massive deletions, as a result of which most of the lectin domain was lost ([Figure S4](#mmc1){ref-type="supplementary-material"}).

Loss of HE Lectin Function Reduces Receptor-Destroying Enzyme Activity toward Multivalent Substrates {#sec2.6}
----------------------------------------------------------------------------------------------------

In influenza C and D viruses, the hemagglutinin-esterase fusion protein is uniquely responsible for viral attachment and entry, and hence HE function is receptor binding first and foremost. The same holds for the HEs of MHV-type murine betacoronaviruses (MuCoV) that mediate virion binding to *O*-Ac-sialoglycan-based attachment factors ([@bib14]), while S binds to the proteinaceous entry receptor CEACAM-1 ([@bib25]). At the other end of the spectrum, in OC43 and HKU1, HE's sole remaining function is receptor destruction, with virion attachment to 9-*O*-Ac-sialoglycans exclusively assigned to S. For the animal β1CoVs that retain a functional HE lectin domain, however, the role of HE is less obvious. On the one hand, HE might participate in attachment to increase virion binding avidity. On the other, its lectin domain may serve primarily to promote catalytic activity toward high-multivalency substrates by bringing the esterase in close proximity to and prolonged association with clustered glycotopes, in analogy with the carbohydrate-binding modules of cellular glycoside hydrolases ([@bib2]). In the latter case, the HE lectin CBS in the human lineage A βCoVs may have been lost to downregulate receptor-destroying activity. To study this, we compared soluble recombinant HEs of BCoV, OC43, and HKU1 for their relative enzymatic activity toward the monovalent substrate p-nitrophenol acetate (pNPA) and the multivalent substrate BSM. The latter glycoconjugate carries hundreds of O-linked glycans clustered in such densities to give the protein a filamentous bottlebrush appearance typical for mucins ([@bib41]). Whereas all three HEs showed comparable specific activities when assayed with pNPA ([Figure 5](#fig5){ref-type="fig"} A), those of OC43 and HKU1 were more than 250-fold less active than BCoV HE in receptor-destruction assays with BSM ([Figure 5](#fig5){ref-type="fig"}B). Inactivation of the BCoV HE lectin CBS through a F^211^A substitution reduced its esterase activity toward BSM to that of wild-type OC43 HE. Conversely, restoration of the OC43 HE lectin domain increased esterase activity to that of BCoV HE (see "TREF," [Figure 5](#fig5){ref-type="fig"}B). Thus, BCoV and HCoV HEs indeed differ in their reactivity toward clustered receptors in consequence of the respective conservation or loss of lectin function.Figure 5Loss of HE Lectin-Mediated Receptor Binding Alters Sialate-9-*O*-Acetylesterase Receptor, Destroying Activity toward Multivalent Substrates(A) Esterase activity of soluble recombinant HE^+^-Fc fusion proteins (sHE^+^) toward monovalent substrate pNPA. Enzymatic activity is shown as percentage of BCoV HE wild-type activity. WT, sHE^+^ with wild-type HE ectodomains of BCoV-Mebus, OC43 USA/1967, or HCoV-HKU1 as indicated; F^211^A, BCoV-Mebus sHE^+^ derivative with the lectin CBS inactivated through a F^211^A substitution ([@bib42]); TREF, OC43 USA/1967 HE with the lectin CBS repaired (as in [Figure 2](#fig2){ref-type="fig"}C). Data are represented as mean ± SEM.(B) Loss of sHE^+^-mediated receptor binding results in reduced esterase activity toward high-multivalency substrates as determined by on-the-plate *O*-Ac-Sia depletion assay. BSM, coated on maxisorp plates, was incubated for 1 hr with 2-fold serial dilutions of sHE^+^. Receptor destruction was assessed by sp-LBA with BCoV HE^0^-Fc at fixed concentration (2 ng/μL).(C) Whole-virion receptor-destruction assays with 2-fold serial dilutions of purified viruses (starting at 15 mU). BCoV and OC43 sHE^+^s were included for comparison. Receptor destruction was measured after 1 hr or 4 hr incubation. Black dotted lines indicate 100% receptor destruction as determined with excess amounts of BCoV or OC43 sHE^+^.(D) Whole-virus-mediated receptor destruction over time with fixed amounts of BCoV-Mebus and OC43 USA/1967 virions (15 mU). To exclude "exhaustion" (inactivation of OC43 esterase and/or changes in the physicochemical properties of the virions over time), we removed BCoV and OC43 at t = 24 and replaced them with equal amounts of freshly thawed aliquots of the virus stocks (black arrow).(E) Scaled side-by-side representations of the structures of coronavirus S ([@bib36]) and HE proteins. Indicated are the estimated heights of S and HE and the approximate distance separating S receptor-binding sites and HE catalytic sites. (See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc1){ref-type="supplementary-material"}.)

Consequences of Loss of Lectin Function for Virion-Mediated Receptor Destruction {#sec2.7}
--------------------------------------------------------------------------------

OC43 HE efficiently depletes endogenous pools of *O*-Ac-Sias within infected cells ([Figure S5](#mmc1){ref-type="supplementary-material"}) as is critical for the release of viral progeny ([@bib7]). The loss of HE lectin function therefore is more likely to affect virus biology at another stage, namely that of virion (pre)attachment. Of note, the observations for recombinant soluble HEs cannot be extrapolated one-to-one to virion-associated HEs, because in virus particles, HE esterase activity will be affected by S-mediated attachment to 9-*O*-Ac-Sias as well as by the close packing of HE molecules in the viral envelope. Serial dilutions of intact BCoV and OC43 virions, adjusted for pNPA esterase activity ([Table S2](#mmc1){ref-type="supplementary-material"}), were therefore compared in solid-phase receptor-destruction assays with BSM ([Figures 5](#fig5){ref-type="fig"}C and 5D). Remarkably, the difference between the two viruses as measured by the onset of detectable receptor destruction was smaller than for their respective soluble HEs.

The activity of virion-associated BCoV HE relative to that of soluble BCoV HE was reduced 8- to 16-fold. Conversely, the relative activity of virion-associated OC43 was increased at least in that destruction of receptors already became apparent at lower enzyme concentrations. ([Figure 5](#fig5){ref-type="fig"}C). To study whether these phenomena relate to the S protein and to S-mediated virion attachment to 9-*O*-Ac-Sias, we constructed recombinant murine coronaviruses (rMuCoVs) that express MuCoV S, which does not bind 9-*O*-Ac-Sias, in combination with either BCoV or OC43 HE. rMuCoV virions studded with OC43 HE lacked detectable esterase activity toward BSM. In contrast, the esterase activity of rMuCoVs expressing BCoV HE was 6- to 8-fold higher than that of wild-type BCoV virions ([Figure 5](#fig5){ref-type="fig"}C). Apparently, β1CoV S proteins, by binding to 9-*O*-Ac-Sias negatively or positively, affect HE esterase activity in BCoV and OC43 virions, respectively, depending on whether or not the HE lectin domain is functional. Most strikingly, BCoV and OC43 virions differed in the extent to which receptors were depleted. The soluble HEs of OC43 and BCoV, despite their difference in enzyme activity, destroyed all *O*-Ac-Sias as detectable by sp-LBA. BCoV virions destroyed 95% of the receptors after 24 hr incubation, which increased to 98% after 48 hr ([Figure 5](#fig5){ref-type="fig"}D). For OC43 virions, the effect was more pronounced such that after 24 hr only 85% of the receptors were destroyed. The remaining receptors were resistant even to continued incubation ([Figure 5](#fig5){ref-type="fig"}D). The data suggest that, in the context of the virion, the absence of a functional HE lectin domain results not only in reduced enzyme activity toward clustered receptors, but also prohibits cleavage of particular receptor populations. As these "protected" receptor populations are readily depleted by soluble OC43 HE ([Figures 5](#fig5){ref-type="fig"}B--5D), their resistance to cleavage by OC43 virions suggests that they are inaccessible to HEs when embedded in the viral envelope and in the presence of S.

The data prompt a model in which the susceptibility of populations of clustered receptors to cleavage depends on (1) their accessibility, as determined by the distance by which they extend from a fixed surface---the bottom of the ELISA well in our artificial system and, for example, the host cell membrane in vivo---and (2) the considerable difference in height between S and HE (20 and 8 nm, respectively), with the CBSs of S and those of HE esterase domains separated by a distance of up to 15 nm ([Figure 5](#fig5){ref-type="fig"}E). S-mediated virion attachment to a 9-*O*-Ac-sialylated surface would bring the HE catalytic site in proximity of some clustered receptors (which would explain the stimulating effect of S on HE esterase activity in the case of OC43 virions, but not observed for rMuCoV-OC43 HE^+^) but at the same time would keep the virus-associated enzyme at "arm's length" from other receptor populations, readily accessible to soluble HEs (which would explain the inhibiting effect of S on esterase activity in the case of BCoV virions and the apparent lack thereof in the case of rMuCoV-BCoV HE^+^) ([Figures 5](#fig5){ref-type="fig"}C and 5D). Thus, a distinction arises between clustered receptor populations that come within immediate reach of the HE esterase and that therefore would be cleaved by virion-associated HE as efficiently as by soluble HE and those that are kept out of reach of virion-associated HE as a result of S-mediated receptor-binding and that are therefore cleaved at strongly reduced rates or even rendered non-cleavable unless HE is provided with a functional lectin domain ([Figure 6](#fig6){ref-type="fig"} ). By virions grasping on to multivalent sialoglycoconjugates via the HE receptor-binding sites and "drawing them in" closer to the surface of the envelope, clustered receptors would yet become available to the HE esterase domain ([Figure 6](#fig6){ref-type="fig"}). Such a mechanism may be promoted by cooperativity among adjacent HE molecules and, membrane fluidity permitting, possibly even lead to redistribution of surface projections in the viral envelope, resulting in displacement of spikes, local recruitment of HEs, and formation of a "receptor-destruction patch." Saliently, some receptor populations may be completely resistant to destruction even by virion-associated HEs with a functional lectin domain, such as the 2% of detectable *O*-Ac-Sias remaining after 48 hr of incubation with BCoV ([Figure 5](#fig5){ref-type="fig"}D). It is tempting to speculate that under natural conditions, the distinction between decoy and entry receptors is made by default on basis of their accessibility to cleavage by virion-associated HE.Figure 6Hypothetical Model for the Interaction of HCoV and BCoV Virions with Multivalent GlycoconjugatesSchematically depicted are portions of HCoV (OC43 or HKU1) and BCoV virions, with large spikes comprised of S (in gray) and smaller protrusions comprised of HE (yellow) extending from the viral membrane (blue). Functional HE lectin CBSs are indicated by black holes (only one shown per HE dimer for reasons of simplicity). Also shown schematically are membrane-anchored (bottom) and non-anchored (top) mucin-type glycoconjugates of bottle-brush filamentous appearance with clustered receptors (9-*O*-Ac-Sias, red dots) arranged in linear arrays and with absence of red dots indicating receptor-destruction. The model, based on the size difference between S and HE, visualizes how loss of HE lectin function might alter virion-associated receptor-destroying activity, reducing the specific activity of virions as well as the rate and selectivity of receptor destruction. In virions with lectin-deficient HEs, clustered substrates will be largely kept at a distance from the HE esterase catalytic pocket as a result of S-glycoconjugate interaction. In contrast, HEs with intact lectin CBS may draw in portions of the glycoconjugates (or will draw the virion-associated HEs toward them), aided by cooperativity of binding between adjacent HEs within the viral envelope. Thus, clustered glycotopes become fixed within reach of the esterase catalytic sites and receptor destruction is promoted.

Conclusion {#sec3}
==========

We showed that OC43---after its zoonotic introduction---has been under incessant selective pressure to adapt to the sialoglycome of the human host. HE-associated receptor binding was selected against, largely lost early on, and ultimately lost altogether through an accumulation of mutations in the lectin domain over a period of decades. In result, the balance between virion attachment and catalytically driven virion elution was reset, apparently to meet the specific requirements for optimal replication in human airways and to allow the virus in this particular niche to distinguish between decoys marked for destruction and functional receptors that should be preserved for cell entry. This view is reinforced by our observation that HCoV-HKU1, another respiratory lineage A βCoV of humans, followed a convergent evolutionary path and also lost HE-mediated receptor binding. We offer that differences in the sialoglycomes of bovids and humans, such as in the local expression, structure, and density of 9-*O*-acetylated sialoglycoconjugates, may pose incompatibilities during cross-species transmission of OC43 and BCoV and that the respective loss or preservation of HE-mediated receptor binding contributes to the host tropism of these viruses. This said, comparative sialoglycomics is still in its infancy, humans and bovids have not been studied for differences in *O*-Ac-sialoglycan expression in any detail, and the precise sialoglycan-based constraints that selected for the particular traits of the animal and human βCoVs therefore remain to be identified. At any rate, our findings do reveal an as yet unappreciated aspect of lineage A βCoV adaptation to humans. Of broader relevance, they provide a general paradigm for dynamic, catalysis-driven virus-sialoglycan interactions in relation to host selectivity. This notion is supported by observations for influenza A viruses, where neuraminidase (NA) activity toward multivalent substrates varies with differences in the length of the stalk domain and positively correlates with NA size ([@bib3], [@bib8]), where NA catalytic activity is modulated by the absence or presence of a second Sia-binding site ([@bib31], [@bib33]) and where changes in NA stalk length and NA lectin affinity have been implicated in host specificity ([@bib1], [@bib3], [@bib12], [@bib19], [@bib20], [@bib24], [@bib31], [@bib33]). These observations can be readily interpreted in the context of our data and model proposed.

Experimental Procedures {#sec4}
=======================

Materials and experimental procedures are detailed in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Expression and Purification of HEs {#sec4.1}
----------------------------------

Human codon-optimized sequences of the HEs of BCoV-Mebus, ECoV-NC99, PHEV-VW572, RbCoV-HKU14-1, CRCoV-240/05, HCoV-HKU1, and OC43 USA/1967 (ATCC VR-759) were cloned in expression plasmid pCD5-T-Fc ([@bib42]). The resulting constructs encode chimeric proteins comprised of the HE ectodomain fused to the human IgG1 Fc domain, with the domains separated by a thrombin cleavage site. The fusion proteins were either expressed in an enzymatically active form (HE^+^) or rendered inactive through a catalytic Ser-to-Ala substitution (HE^0^). Plasmids coding for OC43 NL/A/2005 and OC43 NL/B/2005 HE were constructed through site-directed mutagenesis of the OC43 USA/1967 HE expression vector using the Q5 kit (New England Biolabs). For lectin affinity and esterase activity assays, HE-Fcs were produced by transient expression in HEK293T cells and purified from cell culture supernatants by protein A affinity chromatography and low pH elution as described ([@bib42]). For crystallization, OC43 NL/A/2005 HE^+^-Fc was expressed in HEK293 GnTI(−) cells and purified by protein A affinity chromatography, followed by on-the-beads thrombin cleavage as described ([@bib42]). Beads were pelleted, and the HE ectodomain in the supernatant was concentrated to ∼15 mg/mL. HE genes from OC43 field strains were RT-PCR amplified with OC43 viral RNA, directly isolated from nasopharyngeal aspirates ([@bib32]) as a template, and their sequences were used to construct codon-optimized versions.

Purification of Virions for Whole-Virus Receptor-Destruction Assays {#sec4.2}
-------------------------------------------------------------------

Cell monolayers were infected at MOI 0.01. Virions were purified by ultracentrifugation through 20% (w/v) sucrose cushions and resuspended in PBS. Virus preparations were analyzed for particle content by qPCR, plaque assay, quantitative latex bead ratio EM, and pNPA esterase activity assay ([Table S2](#mmc1){ref-type="supplementary-material"}).

Hemagglutination Assay {#sec4.3}
----------------------

HAA was performed with rat erythrocytes (Rattus norvegicus strain Wistar; 50% suspension in PBS) and, in standard tests, with 2-fold serial dilutions of HE^0^-Fc proteins (starting at 25 ng/well) as described ([@bib42]). For high-sensitivity HAA, based on multivalency-driven high-avidity binding, 5 μg HE^0^-Fc was complexed to 2 × 10^9^ protein A-coated 100 nm nanobeads (Chemicell) in 100 μL PBS for 45 min at 4°C prior to 2-fold serial dilution. Hemagglutination was for 2 hr at 4°C unless stated otherwise.

Solid-Phase Lectin-Binding Assay and On-the-Plate *O*-Ac-Sia Depletion Assay {#sec4.4}
----------------------------------------------------------------------------

sp-LBAs were performed with bovine submaxillary mucin (BSM) and 2-fold serial dilutions of HE^0^-Fc proteins as described ([@bib15], [@bib16]).

Receptor-destroying esterase activities of soluble recombinant HEs (sHE+) and whole viruses were measured by on-the-plate *O*-Ac-Sia depletion assay, performed essentially as described ([@bib16]). BSM, coated on Maxisorp flat-bottom 96-well plates, was (mock-)treated with 2-fold serial dilutions of sHE^+^ in PBS (100 μL/well) starting at 20 ng/μL for 1 hr, or, for whole-virion receptor-destruction assays, with virions or sHE^+^ starting at 15 mU esterase activity for up to 48 hr at 37°C. Depletion of *O*-Ac-Sia receptors was detected by sp-LBA with BCoV-LUN HE^0^ (2 ng/μL; 100 μL/well). Esterase activity was plotted as the inverse of lectin-binding measurements, expressed in percentages.
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Accession Numbers {#app1}
=================

The accession number for the crystal structure of HCoV-OC43 NL/A/2005 HE reported in this paper is PDB: [5N11](pdb:5N11){#intref0015}.
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